World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases

Shareholder Alert: The Ademi Firm investigates whether Confluent Inc. is obtaining a Fair Price for its Public Shareholders

WL Writing Staff by WL Writing Staff
December 8, 2025
in Press Releases
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

MILWAUKEE, Dec. 8, 2025 /PRNewswire/ — The Ademi Firm is investigating Confluent (NASDAQ: CFLT) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with IBM.


Ademi & Fruchter Logo (PRNewsfoto/Ademi LLP)

Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.  There is no cost or obligation to you.

In the transaction, Confluent shareholders will receive $31 per share in cash, representing an enterprise value of $11 billion. Confluent insiders will receive substantial benefits as part of change of control arrangements.

The transaction agreement unreasonably limits competing transactions for Confluent by imposing a significant penalty if Confluent accepts a competing bid. We are investigating the conduct of the Confluent board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi & Fruchter LLP                                 
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-the-ademi-firm-investigates-whether-confluent-inc-is-obtaining-a-fair-price-for-its-public-shareholders-302635400.html

SOURCE Ademi LLP

WL Writing Staff

WL Writing Staff

Related Posts

BTGO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds BitGo Holdings (BTGO) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026

June 25, 2026

In HelloNation, Estate Planning Attorney Hunter Plemmons Breaks Down the Probate Process

June 25, 2026

Arizona Ridge Riders to Announce Multi-Year Partnership with Energy Transfer at 2026 Training Camp this Weekend

June 25, 2026

Big Green Egg’s EGGtoberfest Returns October 3 — Tickets on Sale Now

June 25, 2026

Variant Investments Publishes 2026 Impact Report, Marking Five-Years of Measurable Impact in Private Credit

June 25, 2026

Tigerlily Foundation Celebrates FDA Approval of Trodelvy® as a First-Line Treatment for Metastatic Triple-Negative Breast Cancer

June 25, 2026

Popular News

  • In HelloNation, Estate Planning Attorney Hunter Plemmons Breaks Down the Probate Process

    0 shares
    Share 0 Tweet 0
  • BTGO SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds BitGo Holdings (BTGO) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026

    0 shares
    Share 0 Tweet 0
  • Big Green Egg’s EGGtoberfest Returns October 3 — Tickets on Sale Now

    0 shares
    Share 0 Tweet 0
  • Arizona Ridge Riders to Announce Multi-Year Partnership with Energy Transfer at 2026 Training Camp this Weekend

    0 shares
    Share 0 Tweet 0
  • Variant Investments Publishes 2026 Impact Report, Marking Five-Years of Measurable Impact in Private Credit

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler